Transient or persistent immunosuppression is a known risk factor for morbidity and mortality in critically ill patients. Aim of the present study is to evaluate the lymphopenia in patients admitted to the Emergency Unit of AOU Policlinico Umberto I, to investigate its prevalence at admission and the persistence during hospitalization until discharge. Possible correlations were evaluated between lymphopenia, diagnosis of admission, comorbidities and chronic treatments. In this study, 240 patients (142 men; 98 female; mean age 75.1 ± 15.1) were enrolled. Patients were divided into two groups according to the lymphocytes count at hospital admission, namely “Group A” with lymphopenia and “Group B” with values in the normal range. Moreover, the patients in group A were distinguished in relation to the regression or persistence of the lymphopenia assessed at the time of hospital discharge (Group A1: persistence; Group A2: normalization). Prevalence of lymphopenia at admission was 57%; Group A showed higher mean age and percentage of patients over 65 years of age; and none differences were observed regarding gender. Prevalence of lymphopenia at admission was 57%; Group A showed higher mean age and percentage of patients over 65 years of age; no di erences were observed regarding gender. All subsets of the lymphocytes (CD4+, CD8+, NK) were equally reduced. Persistent lymphopenia was found in 19% of patients. Lymphopenia should be valued at the time of hospital admission as a factor influencing the prognosis, the management, and the treatment of these patients.

Clinical impact of transient lymphopenia / Petramala, Luigi; Milito, Cinzia; Sarlo, Francesca; Servello, Adriana; Circosta, Francesco; Marino, Luca; Sardella, Germano; Trapani, Piero; D'Aguanno, Giulio; Cimo', Antonino; Galardo, Gioacchino; Letizia, Claudio. - In: CLINICAL AND EXPERIMENTAL MEDICINE. - ISSN 1591-9528. - 24:1(2024), pp. 1-10. [10.1007/s10238-024-01340-0]

Clinical impact of transient lymphopenia

Petramala, Luigi;Milito, Cinzia;Servello, Adriana;Circosta, Francesco;Marino, Luca
;
Sardella, Germano;Trapani, Piero;D'aguanno, Giulio;Cimo', Antonino;Galardo, Gioacchino;Letizia, Claudio
2024

Abstract

Transient or persistent immunosuppression is a known risk factor for morbidity and mortality in critically ill patients. Aim of the present study is to evaluate the lymphopenia in patients admitted to the Emergency Unit of AOU Policlinico Umberto I, to investigate its prevalence at admission and the persistence during hospitalization until discharge. Possible correlations were evaluated between lymphopenia, diagnosis of admission, comorbidities and chronic treatments. In this study, 240 patients (142 men; 98 female; mean age 75.1 ± 15.1) were enrolled. Patients were divided into two groups according to the lymphocytes count at hospital admission, namely “Group A” with lymphopenia and “Group B” with values in the normal range. Moreover, the patients in group A were distinguished in relation to the regression or persistence of the lymphopenia assessed at the time of hospital discharge (Group A1: persistence; Group A2: normalization). Prevalence of lymphopenia at admission was 57%; Group A showed higher mean age and percentage of patients over 65 years of age; and none differences were observed regarding gender. Prevalence of lymphopenia at admission was 57%; Group A showed higher mean age and percentage of patients over 65 years of age; no di erences were observed regarding gender. All subsets of the lymphocytes (CD4+, CD8+, NK) were equally reduced. Persistent lymphopenia was found in 19% of patients. Lymphopenia should be valued at the time of hospital admission as a factor influencing the prognosis, the management, and the treatment of these patients.
2024
lymphopenia; clinical frailty; immunosuppression; diabetes; covid-19 infection
01 Pubblicazione su rivista::01a Articolo in rivista
Clinical impact of transient lymphopenia / Petramala, Luigi; Milito, Cinzia; Sarlo, Francesca; Servello, Adriana; Circosta, Francesco; Marino, Luca; Sardella, Germano; Trapani, Piero; D'Aguanno, Giulio; Cimo', Antonino; Galardo, Gioacchino; Letizia, Claudio. - In: CLINICAL AND EXPERIMENTAL MEDICINE. - ISSN 1591-9528. - 24:1(2024), pp. 1-10. [10.1007/s10238-024-01340-0]
File allegati a questo prodotto
File Dimensione Formato  
Petramala_Clinical_2024.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 931.08 kB
Formato Adobe PDF
931.08 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1710650
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact